HBIO · Harvard Bioscience Inc
$6.10
+0.02 (+0.25%)
At close · Jul 27
Going-concern doubt
— cleared May 12, 2026
The latest filing states the doubt was alleviated.
“Management has evaluated the Company's ability to continue as a going concern under ASC 205-40 for the twelve months following the issuance of these financial statements and concluded that the conditions and events that initially raised substantial doubt have been alleviated and that substantial doubt does not exist as of the date of issuance.”View the 10-Q filed May 12, 2026
Market Cap
$27.06M
Shares
4.51M
Stock transactions by members of the U.S. Congress, disclosed under the STOCK Act. Lawmakers must report trades within 45 days, so the filing date can lag the trade itself.
No Congressional Trades
No congressional trading data is available for this stock yet.